These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6423789)

  • 1. Assessment of lead stores in children: validation of an 8-hour CaNa2EDTA provocative test.
    Markowitz ME; Rosen JF
    J Pediatr; 1984 Mar; 104(3):337-41. PubMed ID: 6423789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of iron deficiency on lead excretion in children with moderate lead intoxication.
    Markowitz ME; Rosen JF; Bijur PE
    J Pediatr; 1990 Mar; 116(3):360-4. PubMed ID: 2106578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
    Markowitz ME; Bijur PE; Ruff H; Rosen JF
    Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Need for the lead mobilization test in children with lead poisoning.
    Markowitz ME; Rosen JF
    J Pediatr; 1991 Aug; 119(2):305-10. PubMed ID: 1907320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):685-9. PubMed ID: 2492111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic significance of edetate disodium calcium testing in children with increased lead absorption.
    Saenger P; Rosen JF; Markowitz M
    Am J Dis Child; 1982 Apr; 136(4):312-5. PubMed ID: 6803578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Environ Health Perspect; 1991 Feb; 91():57-62. PubMed ID: 1904023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Environ Health Perspect; 1991 Jun; 93():271-7. PubMed ID: 1773798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using unstimulated urinary lead excretion to assess the need for chelation in the treatment of lead poisoning.
    Berger OG; Gregg DJ; Succop PA
    J Pediatr; 1990 Jan; 116(1):46-51. PubMed ID: 2104929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of urinary lead concentration in interpretation of the EDTA mobilization test.
    Shannon M; Grace A; Graef J
    Vet Hum Toxicol; 1989 Apr; 31(2):140-2. PubMed ID: 2494797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Setting the optimal erythrocyte protoporphyrin screening decision threshold for lead poisoning: a decision analytic approach.
    DeBaun MR; Sox HC
    Pediatrics; 1991 Jul; 88(1):121-31. PubMed ID: 2057248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of 248 initial mobilization tests performed on an ambulatory basis.
    Weinberger HL; Post EM; Schneider T; Helu B; Friedman J
    Am J Dis Child; 1987 Dec; 141(12):1266-70. PubMed ID: 3120575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
    Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
    J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the management of childhood lead poisonings.
    Rosen JF; Markowitz ME
    Neurotoxicology; 1993; 14(2-3):211-7. PubMed ID: 8247394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking the threshold for an abnormal capillary blood lead screening test.
    Sargent JD; Dalton MA
    Arch Pediatr Adolesc Med; 1996 Oct; 150(10):1084-8. PubMed ID: 8859143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man.
    Hansen JP; Døssing M; Paulev PE
    J Occup Med; 1981 Jan; 23(1):39-43. PubMed ID: 6782204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shortened forms of provocative lead chelation.
    Sokas RK; Atleson J; Keogh JP
    J Occup Med; 1988 May; 30(5):420-4. PubMed ID: 3131503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the outcome of the CaNa2EDTA challenge test in children with moderately elevated blood lead levels.
    Campbell JR; Schaffer SJ
    Environ Health Perspect; 1999 Jun; 107(6):437-40. PubMed ID: 10339443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations.
    Graziano JH; Lolacono NJ; Meyer P
    J Pediatr; 1988 Oct; 113(4):751-7. PubMed ID: 2845043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead mobilization test in children with lead poisoning: validation of a 5-hour edetate calcium disodium provocation test.
    Iniguez JL; Leverger G; Dollfus C; Gouraud F; Garnier R; Beauvais P
    Arch Pediatr Adolesc Med; 1995 Mar; 149(3):338-40. PubMed ID: 7858698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.